2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis
© 2022 American College of Rheumatology..
OBJECTIVE: To develop and validate updated classification criteria for giant cell arteritis (GCA).
METHODS: Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 6 phases: 1) identification of candidate items, 2) prospective collection of candidate items present at the time of diagnosis, 3) expert panel review of cases, 4) data-driven reduction of candidate items, 5) derivation of a points-based risk classification score in a development data set, and 6) validation in an independent data set.
RESULTS: The development data set consisted of 518 cases of GCA and 536 comparators. The validation data set consisted of 238 cases of GCA and 213 comparators. Age ≥50 years at diagnosis was an absolute requirement for classification. The final criteria items and weights were as follows: positive temporal artery biopsy or temporal artery halo sign on ultrasound (+5); erythrocyte sedimentation rate ≥50 mm/hour or C-reactive protein ≥10 mg/liter (+3); sudden visual loss (+3); morning stiffness in shoulders or neck, jaw or tongue claudication, new temporal headache, scalp tenderness, temporal artery abnormality on vascular examination, bilateral axillary involvement on imaging, and fluorodeoxyglucose-positron emission tomography activity throughout the aorta (+2 each). A patient could be classified as having GCA with a cumulative score of ≥6 points. When these criteria were tested in the validation data set, the model area under the curve was 0.91 (95% confidence interval [95% CI] 0.88-0.94) with a sensitivity of 87.0% (95% CI 82.0-91.0%) and specificity of 94.8% (95% CI 91.0-97.4%).
CONCLUSION: The 2022 American College of Rheumatology/EULAR GCA classification criteria are now validated for use in clinical research.
| Errataetall: |
CommentIn: Arthritis Rheumatol. 2023 Jun;75(6):1075-1077. - PMID 36622332 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
Arthritis & rheumatology (Hoboken, N.J.) - 74(2022), 12 vom: 07. Dez., Seite 1881-1889 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ponte, Cristina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 16.12.2022 Date Revised 14.02.2024 published: Print-Electronic CommentIn: Arthritis Rheumatol. 2023 Jun;75(6):1075-1077. - PMID 36622332 Citation Status MEDLINE |
|---|
| doi: |
10.1002/art.42325 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM348638264 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM348638264 | ||
| 003 | DE-627 | ||
| 005 | 20240214232613.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/art.42325 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1292.xml |
| 035 | |a (DE-627)NLM348638264 | ||
| 035 | |a (NLM)36350123 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ponte, Cristina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.12.2022 | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Arthritis Rheumatol. 2023 Jun;75(6):1075-1077. - PMID 36622332 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 American College of Rheumatology. | ||
| 520 | |a OBJECTIVE: To develop and validate updated classification criteria for giant cell arteritis (GCA) | ||
| 520 | |a METHODS: Patients with vasculitis or comparator diseases were recruited into an international cohort. The study proceeded in 6 phases: 1) identification of candidate items, 2) prospective collection of candidate items present at the time of diagnosis, 3) expert panel review of cases, 4) data-driven reduction of candidate items, 5) derivation of a points-based risk classification score in a development data set, and 6) validation in an independent data set | ||
| 520 | |a RESULTS: The development data set consisted of 518 cases of GCA and 536 comparators. The validation data set consisted of 238 cases of GCA and 213 comparators. Age ≥50 years at diagnosis was an absolute requirement for classification. The final criteria items and weights were as follows: positive temporal artery biopsy or temporal artery halo sign on ultrasound (+5); erythrocyte sedimentation rate ≥50 mm/hour or C-reactive protein ≥10 mg/liter (+3); sudden visual loss (+3); morning stiffness in shoulders or neck, jaw or tongue claudication, new temporal headache, scalp tenderness, temporal artery abnormality on vascular examination, bilateral axillary involvement on imaging, and fluorodeoxyglucose-positron emission tomography activity throughout the aorta (+2 each). A patient could be classified as having GCA with a cumulative score of ≥6 points. When these criteria were tested in the validation data set, the model area under the curve was 0.91 (95% confidence interval [95% CI] 0.88-0.94) with a sensitivity of 87.0% (95% CI 82.0-91.0%) and specificity of 94.8% (95% CI 91.0-97.4%) | ||
| 520 | |a CONCLUSION: The 2022 American College of Rheumatology/EULAR GCA classification criteria are now validated for use in clinical research | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Intramural | |
| 700 | 1 | |a Grayson, Peter C |e verfasserin |4 aut | |
| 700 | 1 | |a Robson, Joanna C |e verfasserin |4 aut | |
| 700 | 1 | |a Suppiah, Ravi |e verfasserin |4 aut | |
| 700 | 1 | |a Gribbons, Katherine Bates |e verfasserin |4 aut | |
| 700 | 1 | |a Judge, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Craven, Anthea |e verfasserin |4 aut | |
| 700 | 1 | |a Khalid, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Hutchings, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Watts, Richard A |e verfasserin |4 aut | |
| 700 | 1 | |a Merkel, Peter A |e verfasserin |4 aut | |
| 700 | 1 | |a Luqmani, Raashid A |e verfasserin |4 aut | |
| 700 | 0 | |a DCVAS Study Group |e verfasserin |4 aut | |
| 700 | 1 | |a Gatenby, Paul |e investigator |4 oth | |
| 700 | 1 | |a Hill, Catherine |e investigator |4 oth | |
| 700 | 1 | |a Ranganathan, Dwarakanathan |e investigator |4 oth | |
| 700 | 1 | |a Kronbichler, Andreas |e investigator |4 oth | |
| 700 | 1 | |a Blockmans, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Barra, Lillian |e investigator |4 oth | |
| 700 | 1 | |a Carette, Simon |e investigator |4 oth | |
| 700 | 1 | |a Pagnoux, Christian |e investigator |4 oth | |
| 700 | 1 | |a Dhindsa, Navjot |e investigator |4 oth | |
| 700 | 1 | |a Fifi-Mah, Aurore |e investigator |4 oth | |
| 700 | 1 | |a Khalidi, Nader |e investigator |4 oth | |
| 700 | 1 | |a Liang, Patrick |e investigator |4 oth | |
| 700 | 1 | |a Milman, Nataliya |e investigator |4 oth | |
| 700 | 1 | |a Pineau, Christian |e investigator |4 oth | |
| 700 | 1 | |a Tian, Xinping |e investigator |4 oth | |
| 700 | 1 | |a Wang, Guochun |e investigator |4 oth | |
| 700 | 1 | |a Wang, Tian |e investigator |4 oth | |
| 700 | 1 | |a Zhao, Ming-Hui |e investigator |4 oth | |
| 700 | 1 | |a Tesar, Vladimir |e investigator |4 oth | |
| 700 | 1 | |a Baslund, Bo |e investigator |4 oth | |
| 700 | 1 | |a Hammam, Nevin |e investigator |4 oth | |
| 700 | 1 | |a Shahin, Amira |e investigator |4 oth | |
| 700 | 1 | |a Pirila, Laura |e investigator |4 oth | |
| 700 | 1 | |a Putaala, Jukka |e investigator |4 oth | |
| 700 | 1 | |a Hellmich, Bernhard |e investigator |4 oth | |
| 700 | 1 | |a Henes, Jörg |e investigator |4 oth | |
| 700 | 1 | |a Holle, Julia |e investigator |4 oth | |
| 700 | 1 | |a Moosig, Frank |e investigator |4 oth | |
| 700 | 1 | |a Lamprecht, Peter |e investigator |4 oth | |
| 700 | 1 | |a Neumann, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Schmidt, Wolfgang |e investigator |4 oth | |
| 700 | 1 | |a Sunderkoetter, Cord |e investigator |4 oth | |
| 700 | 1 | |a Szekanecz, Zoltan |e investigator |4 oth | |
| 700 | 1 | |a Danda, Debashish |e investigator |4 oth | |
| 700 | 1 | |a Das, Siddharth |e investigator |4 oth | |
| 700 | 1 | |a Gupta, Rajiva |e investigator |4 oth | |
| 700 | 1 | |a Rajasekhar, Liza |e investigator |4 oth | |
| 700 | 1 | |a Sharma, Aman |e investigator |4 oth | |
| 700 | 1 | |a Wagh, Shrikant |e investigator |4 oth | |
| 700 | 1 | |a Clarkson, Michael |e investigator |4 oth | |
| 700 | 1 | |a Molloy, Eamonn |e investigator |4 oth | |
| 700 | 1 | |a Salvarani, Carlo |e investigator |4 oth | |
| 700 | 1 | |a Schiavon, Franco |e investigator |4 oth | |
| 700 | 1 | |a Tombetti, Enrico |e investigator |4 oth | |
| 700 | 1 | |a Vaglio, Augusto |e investigator |4 oth | |
| 700 | 1 | |a Amano, Koichi |e investigator |4 oth | |
| 700 | 1 | |a Arimura, Yoshihiro |e investigator |4 oth | |
| 700 | 1 | |a Dobashi, Hiroaki |e investigator |4 oth | |
| 700 | 1 | |a Fujimoto, Shouichi |e investigator |4 oth | |
| 700 | 1 | |a Harigai, Masayoshi |e investigator |4 oth | |
| 700 | 1 | |a Hirano, Fumio |e investigator |4 oth | |
| 700 | 1 | |a Hirahashi, Junichi |e investigator |4 oth | |
| 700 | 1 | |a Honma, Sakae |e investigator |4 oth | |
| 700 | 1 | |a Kawakami, Tamihiro |e investigator |4 oth | |
| 700 | 1 | |a Kobayashi, Shigeto |e investigator |4 oth | |
| 700 | 1 | |a Kono, Hajime |e investigator |4 oth | |
| 700 | 1 | |a Makino, Hirofumi |e investigator |4 oth | |
| 700 | 1 | |a Matsui, Kazuo |e investigator |4 oth | |
| 700 | 1 | |a Muso, Eri |e investigator |4 oth | |
| 700 | 1 | |a Suzuki, Kazuo |e investigator |4 oth | |
| 700 | 1 | |a Ikeda, Kei |e investigator |4 oth | |
| 700 | 1 | |a Takeuchi, Tsutomu |e investigator |4 oth | |
| 700 | 1 | |a Tsukamoto, Tatsuo |e investigator |4 oth | |
| 700 | 1 | |a Uchida, Shunya |e investigator |4 oth | |
| 700 | 1 | |a Wada, Takashi |e investigator |4 oth | |
| 700 | 1 | |a Yamada, Hidehiro |e investigator |4 oth | |
| 700 | 1 | |a Yamagata, Kunihiro |e investigator |4 oth | |
| 700 | 1 | |a Yumura, Wako |e investigator |4 oth | |
| 700 | 1 | |a Lai, Kan Sow |e investigator |4 oth | |
| 700 | 1 | |a Flores-Suarez, Luis Felipe |e investigator |4 oth | |
| 700 | 1 | |a Hinojosa-Azaola, Andrea |e investigator |4 oth | |
| 700 | 1 | |a Rutgers, Bram |e investigator |4 oth | |
| 700 | 1 | |a Tak, Paul-Peter |e investigator |4 oth | |
| 700 | 1 | |a Grainger, Rebecca |e investigator |4 oth | |
| 700 | 1 | |a Quincey, Vicki |e investigator |4 oth | |
| 700 | 1 | |a Stamp, Lisa |e investigator |4 oth | |
| 700 | 1 | |a Suppiah, Ravi |e investigator |4 oth | |
| 700 | 1 | |a Besada, Emilio |e investigator |4 oth | |
| 700 | 1 | |a Diamantopoulos, Andreas |e investigator |4 oth | |
| 700 | 1 | |a Sznajd, Jan |e investigator |4 oth | |
| 700 | 1 | |a Azevedo, Elsa |e investigator |4 oth | |
| 700 | 1 | |a Geraldes, Ruth |e investigator |4 oth | |
| 700 | 1 | |a Rodrigues, Miguel |e investigator |4 oth | |
| 700 | 1 | |a Santos, Ernestina |e investigator |4 oth | |
| 700 | 1 | |a Song, Yeong-Wook |e investigator |4 oth | |
| 700 | 1 | |a Moiseev, Sergey |e investigator |4 oth | |
| 700 | 1 | |a Hočevar, Alojzija |e investigator |4 oth | |
| 700 | 1 | |a Cid, Maria Cinta |e investigator |4 oth | |
| 700 | 1 | |a Moreno, Xavier Solanich |e investigator |4 oth | |
| 700 | 1 | |a Atukorala, Inoshi |e investigator |4 oth | |
| 700 | 1 | |a Berglin, Ewa |e investigator |4 oth | |
| 700 | 1 | |a Mohammed, Aladdin |e investigator |4 oth | |
| 700 | 1 | |a Segelmark, Mårten |e investigator |4 oth | |
| 700 | 1 | |a Daikeler, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Direskeneli, Haner |e investigator |4 oth | |
| 700 | 1 | |a Hatemi, Gulen |e investigator |4 oth | |
| 700 | 1 | |a Kamali, Sevil |e investigator |4 oth | |
| 700 | 1 | |a Karadağ, Ömer |e investigator |4 oth | |
| 700 | 1 | |a Pehlevan, Seval |e investigator |4 oth | |
| 700 | 1 | |a Adler, Matthew |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Arthritis & rheumatology (Hoboken, N.J.) |d 2014 |g 74(2022), 12 vom: 07. Dez., Seite 1881-1889 |w (DE-627)NLM234543671 |x 2326-5205 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2022 |g number:12 |g day:07 |g month:12 |g pages:1881-1889 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/art.42325 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 74 |j 2022 |e 12 |b 07 |c 12 |h 1881-1889 | ||